Novo Nordisk Chairman Helge Lund is stepping down after clashing with the company’s main shareholder, the Novo Nordisk ...

Shares of drugmaker Novo Nordisk ($NVO) are down at the time of writing following a similar decline the previous day. The ...

Novo Nordisk NVO has moved to convene an Extraordinary General Meeting (EGM) after a rare and public disagreement over board ...

Shares of Novo Nordisk fell around 3% on Wednesday, extending their losses from a day earlier, after the Wegovy maker's top ...

Potential bidders are circling the media company as it weighs its deal options. But financial and regulatory questions hang ...

Shares of Novo Nordisk have dropped as the company's largest investor, Novo Nordisk Foundation, calls for a board overhaul.

A meeting will be held to elect new board members following a disagreement between the board and its majority shareholder.

Novo Nordisk (NYSE:NVO) shares dropped roughly 3.4% in early trading on Wednesday, adding to the previous session’s declines, ...

Netflix revenue is rising, hiring trends are emerging, Novo Nordisk’s boardroom drama escalates, and more news to start your day.

If there was any doubt about who truly runs Danish weight-loss drugmaker Novo Nordisk A/S, Lars Rebien Sorensen just settled it.

Novo, which installed a new CEO in August to launch a turnaround plan, said chair Helge Lund and the other independent directors would step down at an extraordinary shareholder meeting on November 14.

Novo Nordisk's top investor moved to take control of the drugmaker's board on Tuesday, vowing a sharper focus on the key U.S.